摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine | 124935-88-2

中文名称
——
中文别名
——
英文名称
N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine
英文别名
N,N-di-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropylamine;N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenyl-propylamine;N,N-diisopropyl-3-(2-methoxy-5-metlhylphenyl)-3-phenylpropylamine;[3-(2-methoxy-5-methyl-phenyl)-3-phenyl-propyl]-diisopropyl amine;N,N-Diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropylamine;N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropanamine;Diisopropyl-[3-(2-methoxy-5-methyl-phenyl)-3-phenyl-propyl]-amine;3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propan-1-amine
N,N-diisopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine化学式
CAS
124935-88-2
化学式
C23H33NO
mdl
——
分子量
339.521
InChiKey
CCXFTVHDCYNKJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    446.3±45.0 °C(Predicted)
  • 密度:
    0.970±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:bc0d636f44c4fff2b66e50d6237db69c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Copper-catalysed selective hydroamination reactions of alkynes
    作者:Shi-Liang Shi、Stephen L. Buchwald
    DOI:10.1038/nchem.2131
    日期:2015.1
    The development of selective reactions that utilize easily available and abundant precursors for the efficient synthesis of amines is a long-standing goal of chemical research. Despite the centrality of amines in a number of important research areas, including medicinal chemistry, total synthesis and materials science, a general, selective and step-efficient synthesis of amines is still needed. Here, we describe a set of mild catalytic conditions utilizing a single copper-based catalyst that enables the direct preparation of three distinct and important amine classes (enamines, α-chiral branched alkylamines and linear alkylamines) from readily available alkyne starting materials with high levels of chemo-, regio- and stereoselectivity. This methodology was applied to the asymmetric synthesis of rivastigmine and the formal synthesis of several other pharmaceutical agents, including duloxetine, atomoxetine, fluoxetine and tolterodine. Amines are essential in a number of research areas, but a general, selective and step-efficient synthesis has been elusive. Now, the use of a single copper catalyst to transform alkynes into enamines, α-chiral branched alkylamines, and linear alkylamines is described. These transformations have been applied in the preparation of a selection of current pharmaceutical agents.
    利用易得且丰富的原料进行选择性反应,高效合成胺类化合物,是化学研究长久以来的目标。尽管胺在多个重要研究领域(包括药物化学、全合成和材料科学)中占据核心地位,但通用、选择性且步骤高效合成胺的方法仍然需要。本文描述了一组利用单一铜基催化剂的温和催化条件,能够从易得的炔烃原料直接高选择性地合成三大类不同的重要胺(烯胺、α-手性支链烷基胺和直链烷基胺)。该方法被应用于利凡斯的明的非对称合成以及几种其他药物(包括度洛西汀、托莫西汀、氟西汀和托特罗定)的正式合成。胺在多个研究领域中至关重要,但通用、选择性且步骤高效合成一直难以实现。现在,使用单一铜催化剂将炔烃转化为烯胺、α-手性支链烷基胺和直链烷基胺的方法被描述。这些转化已被应用于当前几种药物的制备。
  • 3,3-diphenylpropylamines and pharmaceutical compositions thereof
    申请人:Pharmacia Aktiebolag
    公开号:US05382600A1
    公开(公告)日:1995-01-17
    ##STR1## Novel 3,3-diphenylpropylamines of formula (I) wherein R.sup.1 signifies hydrogen or methyl, R.sup.2, R.sup.3 and R.sup.4 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphanoyl or halogen, and X represents a tertiary amino group -NR.sup.5, R.sup.6, wherein R.sup.5 and R.sup.6 signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and which may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers, their use as drugs, especially as anticholinergic agents, their use for preparing an anticholinergic drug, pharmaceutical compositions containing the novel amines, and methods for preparing the same.
    式(I)的新型3,3-二苯基丙胺化合物,其中R.sup.1表示氢或甲基,R.sup.2、R.sup.3和R.sup.4独立表示氢、甲基、甲氧基、羟基、氨基甲酰基、磺酰基或卤素,X代表三级氨基-NR.sup.5,R.sup.6,其中R.sup.5和R.sup.6表示非芳香烃基,可以相同也可以不同,并且总共含有至少三个碳原子,它们可以与胺氮形成环,它们与生理上可接受的酸盐,当化合物可以是光学异构体时,它们的消旋混合物和单体对映体,它们作为药物的用途,特别是作为抗胆碱能药物的用途,它们用于制备抗胆碱能药物,含有新型胺的药物制剂,以及其制备方法。
  • Process for producing tolterodine
    申请人:Sumitomo Chemical Company, Limited
    公开号:US07268257B1
    公开(公告)日:2007-09-11
    The present invention provides a process for producing tolterodine of the formula (1) or its salt, which comprises a step reacting a compound of the formula (2) with a base to obtain a reaction product; a step reacting the reaction product with a compound of the formula (3) to obtain a compound of the formula (4); and a step eliminating the protective group from the compound of the formula (4), and also provides a process for producing the compound of the formula (3).
    本发明提供了一种生产化合物的过程,该化合物为公式(1)或其盐,包括以下步骤:将公式(2)的化合物与碱反应以获得反应产物;将反应产物与公式(3)的化合物反应以获得公式(4)的化合物;去除公式(4)的化合物中的保护基团的步骤,并提供了生产公式(3)的化合物的过程。
  • Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamine
    申请人:Turchetta Stefano
    公开号:US20060079716A1
    公开(公告)日:2006-04-13
    A process is described for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamine comprising substitution of the sulfonyloxy group of the compound of the formula in which the substituents R and R″ have the meanings stated in the description, in a solvent comprising an ionic liquid, to yield the tertiary amine of the formula and the subsequent deprotection thereof.
    描述了一种制备N,N-二异丙基-3-(2-羟基-5-甲基苯基)-3-苯基-丙胺的过程,包括在含有离子液体的溶剂中,通过替代具有所述描述中所述的R和R″含义的化合物的磺酰氧基来产生该化合物的三级胺,以及随后的去保护步骤。
  • [EN] TOLTERODINE, COMPOSITIONS AND USES THEREOF, AND PREPARATION OF THE SAME<br/>[FR] TOLTERODINE, COMPOSITIONS ET LEURS UTILISATIONS, ET PREPARATIONS DESDITES COMPOSITIONS
    申请人:CIPLA LTD
    公开号:WO2005061432A1
    公开(公告)日:2005-07-07
    Racemic tolterodine free base in crystalline form, tolterodine with improved purity, compositions and uses thereof, and processes of preparing the same.
    左托吡啶盐酸盐的晶体形式,提高纯度的左托吡啶,其组合物和用途,以及制备这些物质的过程。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐